Browsing Research Articles (School of Pharmacy) by Author "Khoza, Star"
Now showing items 1-5 of 5
-
An analysis of the trends, characteristics, scope, and performance of the Zimbabwean pharmacovigilance reporting scheme
Khoza, Star; Masuka, Josiah Tatenda (Wiley-Blackwell, 2020)We aimed to determine the reporting trends and characteristics of Individual Case Safety Reports (ICSRs) from the Zimbabwean national pharmacovigilance system. ICSRs submitted to VigiBaseTM, the World Health Organisation's ... -
Exploring the utility of a spontaneous adverse drug reaction reporting system in identifying drug–drug interactions between antiretrovirals, antitubercular drugs, and cotrimoxazole: a case/non-case analysis
Khoza, Star; Masuka, Josiah Tatenda; Mosam, Anisa (Springer Nature, 2020)Background: Drug–drug interactions (DDIs) cause significant morbidity and mortality, especially in patients with HIV with opportunistic infections such as tuberculosis. However, the literature on quantitative signal detection ... -
An interesting case of carbamazepine-induced Stevens–Johnson Syndrome
Masuka, Josiah Tatenda; Muzopambwa, Garikai; Khoza, Star; Chibanda, Dixon (Springer, 2018)A 29-year-old Black female patient was admitted to a psychiatric ward with symptoms of major depressive disorder with psychosis. The patient was started on amitriptyline 50 mg/day and haloperidol 10 mg/day. On day 4 ... -
A retrospective analysis of applications for registration of generic medicines processed by the medicines control authority of Zimbabwe
Samunda, Brilliant Tinashe; Sithole, Tariro; Khoza, Star (Springer, 2023)Many applications for registration of medicines are rejected because applicants fail to submit or resolve critical deficiencies in the quality, efficacy, and safety of the medicines. The study aimed to establish approval ... -
Situation analysis on the regulation of nanomedicines in Southern Africa
Mudyiwenyama, Linda G.; Khoza, Star; Dube, Admire (Frontiers Media, 2023)Medical products incorporating nanoparticle drug delivery systems (nanomedicines) are therapeutic or imaging agents, which comprise a delivery system within the nanometer size range (1 – 1000 nm). As medical products, ...